Induction of cytokine expression in leukocytes in acute myocardial infarction

Journal of the American College of Cardiology

Volumn 30, Issue 1, 1997, Pages 165-170

  Marx, Nikolaus ^a   Neumann, Franz Josef ^a   Ott, Ilka ^a   Gawaz, Meinrad ^a   Koch, Werner ^a   Pinkau, Tobias ^a   Schömig, Albert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYTOKINE; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; METOPROLOL; MORPHINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; MALE; NORTHERN BLOTTING; PLASMA; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; CONFOUNDING FACTORS (EPIDEMIOLOGY); CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030871475     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00116-2     Document Type: Article

References (38)

1. Simmoons ML, Serruys PW, van den Brand M, Res J, Verheugt FW, Krauss XH. Early thrombolysis in acute myocardial infarction limitation of infarct size and improved survival . J Am Coll Cardiol. 7:1986;717-728.
2. A prospective trial of intravenous streptokinase in acute myocardial infarction mortality, morbidity and infarct size at 21 days . N Engl J Med. 314:1986;465-471.
3. Koren G, Weiss AT, Hasin Y, Appelbaum D, Welber S, Rosenman Y. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 313:1985;1384-1389.
4. O'Rourke M, Daron D, Koegh A, Kelly R, Nelson G, Barnes C. Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. Circulation. 77:1988;1311-1315.
5. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.
6. Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748-755.
7. Lucchesi BR. Leukocytes and ischemia induced myocardial injury. Annu Rev Pharmacol Toxicol. 26:1986;201-224.
8. Entman ML, Smith CW. Postreperfusion inflammation a model for reaction to injury in cardiovascular disease . Cardiovasc Res. 28:1994;1301-1311.
9. Rossen RD, Swain JL, Michael LH, Weakley S, Giannini E, Entman ML. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle a possible initiator of an extra myocardial mechanism of ischemic injury . Circ Res. 57:1985;119-130.
10. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol. 21:1993;537-545.
11. Hearse DJ, Bolli R. Reperfusion induced injury manifestations, mechanisms and clinical relevance . Cardiovasc Res. 26:1992;101-108.
12. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
13. Yarnell JW, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart diseases. Circulation. 83:1991;836-844.
14. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 290:1974;1275-1277.
15. Ikeda U, Ikeda M, Kano S, Shimada K. Neutrophil adherence to rat cardiac myocytes by proinflammatory cytokines. J Cardiovasc Pharmacol. 23:1994;647-652.
16. Youker K, Smith CW, Anderson DC, et al. Neutrophil adherence to isolated adult cardiac myocytes. J Clin Invest. 89:1992;602-609.
17. Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. J Clin Invest. 95:1995;2720-2728.
18. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw. 5:1994;517-531.
19. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 6:1992;2591-2599.
20. Sica A, Matsushima K, Van Damme J, et al. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology. 69:1990;548-553.
21. Molad Y, Haines KA, Anderson DC, Buyon JP, Cronstein BN. Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and β2-integrin expression differently. Biochem J. 299:1994;881-887.
22. Schröder JM, Mrowitz U, Christophers E. Purification and partial biologic characterization of human lymphocyte-derived peptide with potent neutrophil-stimulating activity. J Immunol. 140:1988;3534-3540.
23. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines IL-6 and related molecules (IL-1 and TNF) . FASEB J. 4:1990;2860-2867.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
25. Dreyer WJ, Smith WC, Michael LH, et al. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Circ Res. 65:1989;1751-1762.
26. Dreyer WJ, Michael LH, Nguyen T, et al. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ Res. 71:1992;1518-1524.
27. Kukielka GL, Manning AM, Michael LH, et al. Reperfusion is required for the injunction of chemotactic and intercellular adhesion molecule-1 (ICAM-1) synthesis in ischemic hearts. Circulation. 88:(Suppl I):1993;I-5.
28. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest. 93:1994;1564-1570.
29. Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877.
30. Kukielka GL, Youker KA, Hawkins HK, et al. Regulation of ICAM-1 and IL-6 in myocardial ischemia effect of reperfusion . Ann N Y Acad Sci. 723:1994;258-270.
31. Demczuk S, Baumberger C, Mach B, Dayer JM. Expression of human IL-1 alpha and beta messenger RNAs and IL-1 activity in human peripheral blood mononuclear cells. J Mol Cell Immunol. 125:1987;255-265.
32. Strieter RM, Chensue SW, Standiford TJ, Basha MA, Showell HJ, Kunkel SL. Disparate gene expression of chemotactic cytokines by human mononuclear phagocytes. Biochem Biophys Res Commun. 166:1990;886-891.
33. Bosco MC, Espinoza-Delgado I, Schwabe M, et al. Regulation by interleukin-2 and interferon gamma of IL-2 receptor gamma chain gene expression in human monocytes. Blood. 83:1994;2995-3002.
34. Walz A, Peveri P, Aschauer H, Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil activating factor produced by monocytes. Biochem Biophys Res Commun. 149:1987;755-761.
35. Lonnemann G, Endres S, van der Meer JW, Cannon JG, Koch KM, Dinarello CA. Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol. 19:1989;1531-1536.
36. Oliver JC, Land LA, Oettinger CW, et al. Cytokine kinetics in an in vivo whole blood model following an endotoxin challenge. Lymphokin Cytokin Res. 12:1993;115-120.
37. Rossen RD, Michael LH, Kagiyama A, et al. Mechanism of complement activation after coronary artery occlusion evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complies with human C1q in vivo . Circ Res. 62:1988;572-584.
38. Neumann FJ, Marx N, Gawaz M, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation. 95:1997;2387-2394.